Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Long-term efficacy and safety of lamotrigine for all types of bipolar disorder.

Watanabe Y, Hongo S.

Neuropsychiatr Dis Treat. 2017 Mar 20;13:843-854. doi: 10.2147/NDT.S128653. eCollection 2017.

2.

Non-Compliance and Related Factors in Patients With Bipolar I Disorder: A Six Month Follow-Up Study.

Azadforouz S, Shabani A, Nohesara S, Ahmadzad-Asl M.

Iran J Psychiatry Behav Sci. 2016 Mar 15;10(2):e2448. eCollection 2016 Jun.

3.

Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions.

Samalin L, Vieta E, Okasha TA, Uddin MJ, Ahmadi Abhari SA, Nacef F, Mishyiev V, Aizenberg D, Ratner Y, Melas-Melt L, Sedeki I, Llorca PM.

Sci Rep. 2016 May 16;6:25920. doi: 10.1038/srep25920.

4.

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review.

Fornaro M, De Berardis D, Koshy AS, Perna G, Valchera A, Vancampfort D, Stubbs B.

Neuropsychiatr Dis Treat. 2016 Mar 31;12:719-35. doi: 10.2147/NDT.S100846. eCollection 2016. Review.

5.

Pharmacological Approaches for Treatment-resistant Bipolar Disorder.

Hui Poon S, Sim K, Baldessarini RJ.

Curr Neuropharmacol. 2015;13(5):592-604. Review.

6.

Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial.

Vöhringer PA, Ostacher MJ, El-Mallakh RS, Holtzman NS, Thommi SB, Whitham EA, Sullivan MC, Baldassano CF, Goodwin FK, Baldessarini RJ, Ghaemi SN.

J Clin Psychopharmacol. 2015 Oct;35(5):605-8. doi: 10.1097/JCP.0000000000000384.

7.

Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial.

El-Mallakh RS, Vöhringer PA, Ostacher MM, Baldassano CF, Holtzman NS, Whitham EA, Thommi SB, Goodwin FK, Ghaemi SN.

J Affect Disord. 2015 Sep 15;184:318-21. doi: 10.1016/j.jad.2015.04.054. Epub 2015 Jun 10. Erratum in: J Affect Disord. 2016 Jan 15;190:895.

8.

A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis.

Sajatovic M, Davis MS, Cassidy KA, Nestor J, Sams J, Fuentes-Casiano E.

Patient Prefer Adherence. 2015 Jun 8;9:753-8. doi: 10.2147/PPA.S81724. eCollection 2015.

9.

Medication-free Alternatives for Long-term Maintenance of Bipolar Disorder: A Case Series.

Gurevich MI, Robinson CL.

Glob Adv Health Med. 2015 Mar;4(2):53-60. doi: 10.7453/gahmj.2014.064.

10.

Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.

Epstein RA, Moore KM, Bobo WV.

Drug Healthc Patient Saf. 2014 Dec 24;7:7-29. doi: 10.2147/DHPS.S50556. eCollection 2015. Review.

11.

Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity.

Bauer R, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Murray G, Ritter P, Lewitzka U, Severus E, Whybrow PC, Bauer M.

Int J Bipolar Disord. 2013 Dec 9;1:26. doi: 10.1186/2194-7511-1-26. eCollection 2013.

12.

Searching the internet for health information about bipolar disorder: some cautionary issues.

Monteith S, Glenn T, Bauer M.

Int J Bipolar Disord. 2013 Oct 17;1:22. doi: 10.1186/2194-7511-1-22. eCollection 2013. Review.

13.

Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data.

Bauer M, Glenn T, Alda M, Sagduyu K, Marsh W, Grof P, Munoz R, Severus E, Ritter P, Whybrow PC.

Int J Bipolar Disord. 2013 May 3;1:5. doi: 10.1186/2194-7511-1-5. eCollection 2013.

14.

Pharmacotherapy of Bipolar Affective Disorder: A Hospital based Study from Sub Himalayan Valley of Nepal.

Banerjee I, Sathian B, Chakraborty PK, Banerjee I, Roy B, Jauhari AC, Saha A.

J Clin Diagn Res. 2014 Jun;8(6):HC22-7. doi: 10.7860/JCDR/2014/8661.4524. Epub 2014 Jun 20.

15.

Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study.

Pan PY, Lee MS, Lo MC, Yang EL, Yeh CB.

BMC Psychiatry. 2014 May 19;14:145. doi: 10.1186/1471-244X-14-145.

16.

Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.

Nierenberg AA, Sylvia LG, Leon AC, Reilly-Harrington NA, Shesler LW, McElroy SL, Friedman ES, Thase ME, Shelton RC, Bowden CL, Tohen M, Singh V, Deckersbach T, Ketter TA, Kocsis JH, McInnis MG, Schoenfeld D, Bobo WV, Calabrese JR; Bipolar CHOICE Study Group..

Clin Trials. 2014 Feb;11(1):114-27. doi: 10.1177/1740774513512184. Epub 2013 Dec 17.

17.

Prolonged hypothermia due to olanzapine in the setting of renal failure: a case report and review of the literature.

Kansagra A, Patel S, Wilcox SR.

Ther Adv Psychopharmacol. 2013 Dec;3(6):335-9. doi: 10.1177/2045125313490304. Review.

18.

Bipolar depression: clinically missed, pharmacologically mismanaged.

Lloyd LC, Giaroli G, Taylor D, Tracy DK.

Ther Adv Psychopharmacol. 2011 Oct;1(5):153-62. doi: 10.1177/2045125311420752.

19.

Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.

Kulkarni J, Filia S, Berk L, Filia K, Dodd S, de Castella A, Brnabic AJ, Lowry AJ, Kelin K, Montgomery W, Fitzgerald PB, Berk M.

BMC Psychiatry. 2012 Dec 17;12:228. doi: 10.1186/1471-244X-12-228.

20.

Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.

Dusetzina SB, Farley JF, Weinberger M, Gaynes BN, Sleath B, Hansen RA.

Psychiatr Serv. 2012 Oct;63(10):1019-25.

Supplemental Content

Support Center